Remove topics pharmaceutical-industry
article thumbnail

Balancing Innovation: India’s Views for Pharmaceuticals in the Efta Trade Deal

IIPRD

[iii] Understanding the intricacies of the negotiations thus, becomes even more critical when we consider the actualities of the pharmaceutical industry. The implementation of TRIPS-Plus provisions can also readily facilitate the emergence of monopoly power for brand-name pharmaceutical companies. [v]

article thumbnail

A Place Where Science Business Meet: My Internship Experience at AstraZeneca Canada

IPilogue

I also had the pleasure of working with Cristina Aguirre, Privacy Officer at AstraZeneca, and learned about the day-to-day operations of a major pharmaceutical company from her perspective. As a multinational pharmaceutical company, AstraZeneca is often involved in complex patent litigation.

Business 106
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

[Sponsored] Short Course on ‘Pharmaceuticals and IP’ by British Institute of International and Comparative Law [March 4 – May 13]

SpicyIP

We’re pleased to inform you that The British Institute of International and Comparative Law (BIICL) is offering a short course on ‘Pharmaceuticals and Intellectual Property’ from 4th March 4 to 13th May, 2022. Short course: Pharmaceuticals and Intellectual Property. Course Topics. Course tutors.

article thumbnail

Journey Through “Augusts” on SpicyIP (2005 – Present)

SpicyIP

Mashelkar, Patents, Industry Funding, and Bias : In August of 2009, Prashant wrote about the Government of India’s acceptance of the conclusions of the Mashelkar Committee Report. However, the controversy arose more over the issue of bias and industry funding. He wrote detailed posts on this topic later here and here.

IP 105
article thumbnail

Patent – a shield for modern biotechnology

Biswajit Sarkar Copyright Blog

The topic of interest is related to both the cellular and molecular aspects of biological objects. Biotechnological advancements have strong implications in the pharmaceutical and food industries as well as in genetic modifications in animals, microorganisms, and plants. What are the biotechnological inventions?

Patent 92
article thumbnail

Life Sciences Strategy Summit on IP & Exclusivity returns to Munich with special IPKat readers’ discount

The IPKat

This year’s summit follows the launch of the Unified Patent Court (UPC) and will inter alia allow participants to understand the industry’s reaction to the new court system and have candid discussions with European life science intellectual property experts. The IPKat has also negotiated a special discount for readers.

IP 52
article thumbnail

Webinar on ‘Trade Secret and Access to Medicine’ by CUSAT and TWN [September22]

SpicyIP

The pharmaceutical sector is one such industry where trade secrets have been used to veil information which is vital to the general public. However, trade secrets though being considered as an IP does not fulfill some of these objectives. Levine, Elon University School of Law: Trade Secrets and Public Policy.